Gesynta Pharma AB
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis (NCT07260669) | Gesynta Pharma AB | 2025-10-15 |
| A Study to Investigate Safety of GS-248 and Efficacy on Raynauds' Phenomenon in Systemic Sclerosis (NCT04744207) | Gesynta Pharma AB | 2020-12-29 |
| A Study in Healthy Subjects to Evaluate Pharmacokinetics and Food Effect After Dosing of GS-248 (NCT04617509) | Gesynta Pharma AB | 2020-03-31 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-248 (NCT04036227) | Gesynta Pharma AB | 2019-07-03 |
Track Gesynta Pharma AB automatically
Every clearance here is in the API, with alerts when new ones post.